Can-Fite BioPharma Ltd. CANF

$CANF putting in a double bottom. watch for vol. not much moving today so may move out of now where

$CANF $6 breaks $6 and we can easily see new highs

$CANF feels like it wants to go again

Oh ôi bsck to negstive???

Oh o better run

Đớn for now??

$CANF Hoping this stud gets a prom date soon‼️

Can-Fite Biopharma $CANF has 2 splits
May 10, 2019 - 1 for 15 reverse split
January 09, 2023 - 1 for 10 reverse split

$CANF
March 3rd release highlights Namodenoson's ability to increase adiponectin levels, a key cytokine known to drive multi-organ protective effects. Importantly, the manuscript underscores Namodenoson's dual role as both an anti-cancer therapy and a protective agent for normal tissues, setting it apart from conventional chemotherapy and other oncology treatments with significant toxicity.

That said… what is holding $CANF back❓- I don’t see it.

$CANF
I’ve been watching and aware of Can-Fite for about 18 months. I saw the RS happen when I assume they needed to raise capital but based on what I heard on the investor call this week they have the working capital now to take the company to the next level AND dare I say profitability…

Currently:
18 months money in hand and strong pipeline of potential patients for study. Current phase 2 & 3 trials have created new opportunities for Namodenoson and Piclidenoson - including but not limited to, Pancreatic cancer w/ potential cure, NASH, E.D., weight loss and Disappearance of decompensated liver cirrhosis, just to name a few.

$CANF is being paid millions for development of treatment for Osteoarthritis in dogs. *This alone should make Can-Fite a 4$ stock, imo.